Status:
RECRUITING
COVID-19 Vaccines Safety Tracking (CoVaST)
Lead Sponsor:
Masaryk University
Conditions:
Adverse Reaction to Vaccine
COVID19 Vaccine
Eligibility:
All Genders
18+ years
Brief Summary
This project aims to monitor the side effects of COVID-19 vaccines worldwide actively. The primary objectives of the project include a) to estimate the prevalence of each local and systemic side effec...
Detailed Description
Introduction: COVID-19 vaccines are the foremost asset to overcome the ongoing pandemic; therefore, mass vaccination has become a high priority for the world's governments. While vaccination strategi...
Eligibility Criteria
Inclusion
- HCW, OA and ST who received COVID-19 vaccine.
- Participating subjects should be at least 18-year-old and able to give their informed consent independently.
Exclusion
- Non HCW, OA and ST who received the COVID-19.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
30000 Patients enrolled
Trial Details
Trial ID
NCT04834869
Start Date
April 1 2021
End Date
December 31 2026
Last Update
April 6 2022
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
American College of Physicians
Philadelphia, Pennsylvania, United States, 19106
2
McMaster University
Hamilton, Ontario, Canada
3
University of Split
Split, Croatia
4
Masaryk University
Brno, Czechia